2-(3-Fluorophenyl)-4-methylthiazole-5-carboxylic acid, 5g

(S,Z)-Ethyl 3-(2,2-dimethyl-1,3-dioxolan-4-yl)acrylate, 95.0%, 10g

2,3-Difluoro-4-[(trans-4-propylcyclohexyl)methoxy]anisole>98.0%(GC)5g

(S)-4-Amino-5-ethoxy-5-oxopentanoic acid hydrochloride, 97%, 100mg

1-Methyl-3,5-diphenyl-1H-1,2,4-triazole, 98.0%, 1g

5-(Methoxymethyl)-2-furoic acid, 98.0%, 100mg

5-Chloro-2-pyridinethiol, 95.0%, 5g

3-[(propylamino)methyl]phenol hydrochloride, 95.0%, 1g

ETHYL 4-AMINO-2-ETHYLSULFANYL-PYRIMIDINE-5-CARBOXYLATE, 97.0%, 1g

GC capillary column ROTI®Cap-1701, 30 m, 0.32 mm, 0.35 µm, 1 Piece(s)

4-Nitro-2,1,3-benzothiadiazole>98.0%(GC)25g

2-(AZETIDIN-3-YL)-5-METHYLPYRIMIDINE, 95.0%, 250mg

1-Chloro-2-(cyclopropylmethoxy)-4-methyl-5-nitro-benzene, 98%, 10g